{"name":"AVM Biotechnology Inc","slug":"avm-biotechnology-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AVM0703","genericName":"AVM0703","slug":"avm0703","indication":"Other","status":"phase_2"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Proton pump inhibitor","genericName":"Proton pump inhibitor","slug":"proton-pump-inhibitor","indication":"Gastroesophageal reflux disease (GERD)","status":"marketed"}]}],"pipeline":[{"name":"AVM0703","genericName":"AVM0703","slug":"avm0703","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Proton pump inhibitor","genericName":"Proton pump inhibitor","slug":"proton-pump-inhibitor","phase":"marketed","mechanism":"Proton pump inhibitors block the hydrogen/potassium ATPase enzyme in gastric parietal cells, reducing gastric acid secretion.","indications":["Gastroesophageal reflux disease (GERD)","Peptic ulcer disease","Zollinger-Ellison syndrome","Prevention of NSAID-induced ulcers"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxNVXpCV25oMmg5aTBBVVZ2cGd1OG9aLUR0aTJJQ2ZHeXQ2TWdHU0gweVlLZ2dXbmVhLXlCaG55X1d2M18yT1J2bk5QbEtXY0JoYWZtbmVrWV96MHVBcW4yOWNaMDhVbWtDTGh1Vkc1UG05em1PaGhVYVRpcFZmbUhCaXBYVU5NcGNXbGljY29fSVUwTzhabmUzSDg3OXk1RS1zc0drUFBPSXJ5WFVyVmZ4RXRVSG92Tk11cFJoVG5sdmFxZTNJdk4wNmQ1VTBGSnNUZ09fbXN4NGpRZEgxYUJzZURPclZ3WnFjNlhaclEwWXBCSGZqdC1QMzNaMXU?oc=5","date":"2026-04-07","type":"trial","source":"Barchart.com","summary":"Influenza Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com","headline":"Influenza Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Develop Drugs for Market Entry | Delve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPNC1HXzBfbVpNVG83WXQ5ekVkQmRDUXU4Tkd1WVBGNnhJRTgweVBlUWNna2IwVWZKWUdvVk1UbDlKa0Qybm5FRDZDc2pJbDhhNl9XSDA2eHVSVkdOX0VQVHBpcEtVbFRmaVZlM1NkNElxLV9UUmVxVlBYY3RHR1hBRHp1SS0zMTB3anhabGlCN2JtZzZYX000N3FsT2o?oc=5","date":"2026-03-20","type":"trial","source":"openPR.com","summary":"B-Cell Lymphomas Clinical Trial Pipeline Appears Robust With - openPR.com","headline":"B-Cell Lymphomas Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNcmQ1ZTBrX29KUDNucTg5bDNLeE1FMEFkSTNlS1EtR2tOcjlmOWlxUldwNlBHVTY1aTJwYXRiejFHeGZXc0VnclNITkhGUnpfeDVuOHBhS2hFTVV6TE5PWmdzSTBIN0hxVHNzeUtRMXJmVnRMMW81UHZ5WTVMZktrd0h0cmNpQlNDWG5Sb2l4ZVVmbWFMaTV30gGcAUFVX3lxTFBrVy01SU1ZMHFpWUpLUTYxcHd6VUMyd0RvWUQtLUlwT21PbFp6WjNJUldDaE00NVRmeUZjUkw3MDRLSlZPbFN0cjJqa3BmUURVU0g5bHlGX25YOU1EVElXUF83QWMxQkJxVDF0clp4ZmtlZ3hzd0NYQVdEX1d3ODEyVGcwRko3MEU0c3h0eWNSYlFrLU5lNkxLeVpzXw?oc=5","date":"2026-02-10","type":"trial","source":"ABC News","summary":"Steroid dexamethasone reduces COVID-19 deaths among seriously ill patients, UK study suggests - ABC News","headline":"Steroid dexamethasone reduces COVID-19 deaths among seriously ill patients, UK study suggests","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxQcTdsYVlJVHNQZUNfejdYdU9weUR0VUlfdkNDVXBnTTJVT2RBa3g2WFNmZUJwUFNzbTVqTWVCSUZHRzMwSTFteUh4NVJDZV9wU2hsQkJaNkNxZXpTdTR5R0MtMmN2Wk1TQjcyRGM3QjQ2S211emhhYnh0bDcweXlBSTFodjFWenVCSDdqVmotSm5sblkzSDJZVzZ1OW52bjNLZ1BLQU1ad3JUM3J2bjUxRTZLbnpCVE9XUXN0WXVJTmp0TUJUVHpIdHFMYnJnRkhnQm1rdUplLUhpSTkxYXFSeDlhTmFQQnBZUTVpMVpiU0t1ODJZUHZvbFNlXzhwak5IblJpcTNEeUpQV1Q1a2Nlb3QzODE?oc=5","date":"2025-10-28","type":"pipeline","source":"prnewswire.com","summary":"CAR T-cell Therapy Market Forecasts Indicate Strong Growth Trajectory in the 7MM During the Forecast Period (2025-2034) | DelveInsight - prnewswire.com","headline":"CAR T-cell Therapy Market Forecasts Indicate Strong Growth Trajectory in the 7MM During the Forecast Period (2025-2034) ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVVE4amRyYjREY2xzQ0NyTDd2YzVCSTVRbTdDUDE3bFF1dm5Hc2REdm9LLU1DSVFuZUxOMU1lWDFNeFd0Qk1pbDh2VGpFMkNHYUVFbllWa195MXlPanVRMjlTckJmR0ZNMVdHdy1wX0t0MmVqSTBCdm1LcDQ1ZWpHZmh2SlJuenJOLU5hOTNTb2NtLXpUT0x3MzNTRTZNcl9wYXZvMkhUZWQ3c2ZabUxfcHRITFdWS3ZhRFVfNFlmNjlnSWJ3dUIwbUdrSXVmcHBjVXpQbGJyUzhkRVFQSnplOA?oc=5","date":"2025-10-10","type":"deal","source":"GlobeNewswire","summary":"AI Technology Group Signs Definitive Agreement to Acquire AVM Biotechnology - GlobeNewswire","headline":"AI Technology Group Signs Definitive Agreement to Acquire AVM Biotechnology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPSGhnWkIwbTRiS1BnbmdtSFhqR0QzbU4xUFQ4bnpQekdjMWdXVW1xYXVja214b2JXOGNCNV9VYVBJRDEyS0pzaGtfekxXRzZyd1M2bXpnclRMdzFYWUZvODVJSzJXcHJJUzNXRFo3ODhOQmhRc2hiMktKTDNFVjFfdUszaE8wdWFwMThDOUsxeUFyZU1XMi1Xb0dRTVFnRV9IcExRWUc5R1BZTDZjNFpObkE1TnFzdWdOQkxWcXFWSVQzLXFqNVlqMUNsUWlnUVlkOTQtU1dOUGlrN25vSXd2LUEyZDNuSGxSQVd4ZEhoRTdDM28tRmdXdzl5eHhDaG50Tzl0TWZJdW0?oc=5","date":"2025-08-27","type":"pipeline","source":"prnewswire.com","summary":"Diffuse Large B-cell Lymphoma Market to Grow at a CAGR of 13% by 2034 in Leading Markets (US, EU4, UK, and Japan) | DelveInsight - prnewswire.com","headline":"Diffuse Large B-cell Lymphoma Market to Grow at a CAGR of 13% by 2034 in Leading Markets (US, EU4, UK, and Japan) | Delv","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxNYzljUUxkSjMwWE1pS0c4Z0RkbGlLMFFEZXhVUnRRTlV3dGxkSE9MN08wWm5ocXpPRnJsUHdsbEY2S0k2bl9NTnZXcnM5cHphdjh4bHFkY1NqbWtqWE1USjRFaG1YbVJaSUJPdnNtMFpYdXpNMHo4ZU9Kb0pPU1k5ZVJMUzBsc0lMTFFtRWdmZUExTUtreE9LN1pTNDZqRXBFVHQ3MUNOejJMTXl4Sk5NSWNiMWVwNkhyR280ZF90dTVZWFVFOF95WEpJeWZDbHRaR1JEZ1BYNFVxUQ?oc=5","date":"2025-03-11","type":"pipeline","source":"PR Newswire UK","summary":"BREYANZI Demonstrates Continued Growth in the Competitive CAR-T Market | DelveInsight - PR Newswire UK","headline":"BREYANZI Demonstrates Continued Growth in the Competitive CAR-T Market | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxQWW9URExNTUgzUnZfbnpxV0dZWUVHTEpzdHRuZW1nMTlURTRVaVhsZDZVTlNmU2VfV2ZjZnoyclY5cVZNNmROVm5NQnZmNjJfcEdkLWZIZmIyaUtWNV9HQ3ozYWRSd254RUY1ZU04WVh0U3NDQmM2SGdITGw3a0w5UWZUTElWUURIc1hFa3RONVE5VnJxZXZFQmw4MkhQSF9iRy1BN1FNdjBVSTNmOXlJVmp5X01LdFZRc25fNlJ1R1Z4Q0dYejJkVWdpOEtnR1NPX1o0NGRvLUFPT1UxOG9KVzBpWkphWWZXX0E?oc=5","date":"2023-09-11","type":"pipeline","source":"businesswire.com","summary":"AVM Biotechnology Selected by the National Cancer Institute to Present at Bio Investor Forum 2023 - businesswire.com","headline":"AVM Biotechnology Selected by the National Cancer Institute to Present at Bio Investor Forum 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxOUkx6T3BCRDZ2SERHTTMwOTc3M1Fydm1oTXE4TnpEOFlfX1pnV0t5Yy1VdUVQSGpCSWFXcjdtaUhxbFJmTGJsSmxQVFY3TTA0bkJ5Y1dxdlBYTnA2TTlCMHRDSTNLQzdacjNSTDVsUmlacktfUHdSMWpRNTZrbkpWUUF5RVZVQ3hjdUUtSkVpUXkzbExMdFF4VjVBZ2NqcDA0V29VWU5qalQwUVR2RmZ1Y2tXUVZ3MGpldXFnaEJ1d2FYWlE4elBYYmpmaWh6NFprZHRMbUVjRFp0dmpkY0NJS3dwYTl0aVBTVllobVk4LWhJYnUzY1RxdWxnZGVSeHE2cTgwMGR5LTBBV2ZXaHY2cWRrU0tUQUxIRjV1QWYwczRvYUtWTEZDQVJVM0w0UQ?oc=5","date":"2023-08-01","type":"pipeline","source":"BioSpace","summary":"AVM Biotechnology Announces Twenty-Eight (28) Solid Tumor and Blood Cancer Patients have been Treated with Immunomodulatory AVM0703 through Expanded Access/Compassionate Use Programs - BioSpace","headline":"AVM Biotechnology Announces Twenty-Eight (28) Solid Tumor and Blood Cancer Patients have been Treated with Immunomodulat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOQ2oxQ3ZwUngxUXl4WnRoX3ctR0M3VTlRS09FQlNma00wdjVzbm9iYzByaDdNNUNacGdkYk1DUUhOZEpUQnFSd3hrbmI5RTF4ZE0xTVk3LUwyXzJabWotSVJxUHpwbzVGWHMyRU9qbmhkQjlJaG4zYnFWZ2VZakdFLXFxM2NLWWtjdC1TTTRNRllXanlXWmI4?oc=5","date":"2022-05-12","type":"trial","source":"TMX Newsfile","summary":"Global Wellness Readies for First Clinical Trial - TMX Newsfile","headline":"Global Wellness Readies for First Clinical Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxNRlE4dVBCdDFUVWgzR1VXYzVZT3lTczNJNFFVZzl3UzExejE5UHJHTm1QTTZnclFncy1tM0lGZGpwajBYWWR3alVEQ0ExRlQ1YVBMVU5RQ05wZmJKSXFSTFlLZVNtUm0ybnUzSW5rS1pJWE9VczFVNEhkRnNpeEV2cEVoXzVDLTBENmVLZ0tYQkpCemlGNGJZR2VITVNoOE5yU20tNDJwNVEyU2w4TExsaFI2ajVTYXMzUlhKTjE4V3lGZHpJR2ZLUi1qVnRUc01QNzVtVVVHZndnbU1aVjA5YjNWejdtMFpMeFNWM21IdENoVWhPOXJJNy1yWE9KRUZPR0YwQUpfNkFDVHZhcERHYlMyYU8?oc=5","date":"2022-04-19","type":"trial","source":"businesswire.com","summary":"AVM Biotechnology Founder and CSO to Present Company Information and Clinical Trial Progress at Life Science Innovation Northwest - businesswire.com","headline":"AVM Biotechnology Founder and CSO to Present Company Information and Clinical Trial Progress at Life Science Innovation ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxQZzFGYi1DUF8wMGlya1Z5R3JEd3hiY3g1Z2t3Ml9EeGJqb1F2QWc4WWVMSGhFV25KUzlYV2k3RXFCdjdPQmJ0RU9tMGZYSmwta3ZXTkpINVB5M0hYa0ZncVZxbm5FYXl3VDBBNndOVllOdUZ0YTRxQ3Uwc0lSMUhxZE16Q3JsMGtOZWVsLXZOTE9ObFZNTmM3V1VYVU1veE50bU5sV1RFSE5yYjVxMW8yX091R0JpSmpkeTNZREl4Q1ZlV3JNMzRvekZPTHF3clFtUVN2ejBvS3kxdE9oeWY1ZUNEZ0pYVWxXaThJOTlIYUdJR2xWSTNMWjFWM2M1bG5HUEZyc2pnZU9wOV80S1NkWkM3ZFc5NUhYMWNodWZxTF9jQQ?oc=5","date":"2021-01-20","type":"regulatory","source":"BioSpace","summary":"AVM Biotechnology's Executive Leadership Team Joined by Dr. Manon Cox, MBA, former Protein Sciences Corporation CEO and Dr. Gary Grohmann, former Australian Regulatory Official - BioSpace","headline":"AVM Biotechnology's Executive Leadership Team Joined by Dr. Manon Cox, MBA, former Protein Sciences Corporation CEO and ","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}